Erin Weeda to Cardiovascular Diseases
This is a "connection" page, showing publications Erin Weeda has written about Cardiovascular Diseases.
Connection Strength
1.103
-
Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk. J Diabetes Complications. 2018 02; 32(2):210-215.
Score: 0.349
-
Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis. Int J Cardiol. 2016 Aug 01; 216:104-9.
Score: 0.316
-
Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease. Ann Pharmacother. 2016 06; 50(6):475-85.
Score: 0.312
-
An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems. J Manag Care Spec Pharm. 2020 Sep; 26(9):1090-1098.
Score: 0.107
-
Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review. Curr Med Res Opin. 2016 07; 32(7):1281-90.
Score: 0.020